Stockscreener 앱 받기
8.72
6.24%
-0.58
시장 영업 전:
8.39
-0.33
-3.78%
전일 마감가:
$9.30
열려 있는:
$9.21
하루 거래량:
734.37K
Relative Volume:
2.66
시가총액:
$462.94M
수익:
-
순이익/손실:
$-83.74M
주가수익비율:
-5.4161
EPS:
-1.61
순현금흐름:
$-64.98M
1주 성능:
-15.42%
1개월 성능:
-25.53%
6개월 성능:
-61.82%
1년 성능:
-48.34%
1일 변동 폭
$8.66
$9.41
1주일 범위
$8.66
$10.87
52주 변동 폭
$8.66
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
명칭
Tyra Biosciences Inc
전화
(619) 728-4760
주소
2656 STATE STREET, CARLSBAD
TYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
8.72 | 462.94M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-07 | 개시 | UBS | Buy |
| 2024-10-18 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-08-15 | 개시 | Piper Sandler | Overweight |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-30 | 개시 | Wedbush | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-06-23 | 개시 | H.C. Wainwright | Buy |
| 2022-03-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Jefferies | Buy |
모두보기
Tyra Biosciences Inc 주식(TYRA)의 최신 뉴스
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $30 target on Tyra Biosciences stock By Investing.com - Investing.com Canada
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by Swiss National Bank - Defense World
What is Wedbush’s Estimate for TYRA FY2029 Earnings? - Defense World
Wedbush Reiterates “Outperform” Rating for Tyra Biosciences (NASDAQ:TYRA) - Defense World
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth - Yahoo Finance
Charles Schwab Investment Management Inc. Trims Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Tyra Biosciences Advances Precision Medicine Pipeline - TipRanks
Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights - MarketScreener
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Bought by Bank of New York Mellon Corp - Defense World
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges By Investing.com - Investing.com South Africa
Tyra Biosciences stock hits 52-week low at $9.9 amid market challenges - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
Victory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthc - GuruFocus.com
US Bancorp DE Purchases Shares of 3,612 Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - NewsBreak: Local News & Alerts
Tyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase – Should You Buy? - Defense World
Tyra Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
(TYRA) On The My Stocks Page - Stock Traders Daily
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges By Investing.com - Investing.com South Africa
Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight - GlobeNewswire Inc.
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Large Growth in Short Interest - Defense World
Advanced Urothelial Carcinoma Clinical Trial Pipeline - GlobeNewswire
Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire
Non-Muscle Invasive Bladder Cancer Clinical and Non-Clinical - openPR
(TYRA) Investment Report - Stock Traders Daily
Tyra Biosciences: FGFR1/2 Driven AE Data Spooked The Market - Seeking Alpha
Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) Price Target at $30.50 - Defense World
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month LowTime to Sell? - MarketBeat
Tyra Biosciences stock hits 52-week low at $11.88 amid market shifts - Investing.com Canada
(TYRA) Investment Analysis - news.stocktradersdaily.com
Tyra Biosciences Inc (TYRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Tyra Biosciences' (TYRA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Given “Buy” Rating at HC Wainwright - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Up 6.6%Here's What Happened - MarketBeat
Non-Muscle Invasive Bladder Cancer (NMIBC) Drugs Market 2034: - openPR
Tyra Biosciences director Nina Kjellson sells $78,466 in stock - MSN
Tyra Biosciences director Nina Kjellson sells $74,323 in stock - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week LowShould You Sell? - MarketBeat
Nina S. Kjellson Sells 5,401 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock - MarketBeat
Exclusive: Tyra Biosciences Sets Ambitious 4-Conference Roadshow Including Prestigious Biotech on the Beach - StockTitan
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year LowHere's What Happened - MarketBeat
An Analysis of Tyra Biosciences Inc (TYRA)’s Potential Price Growth - Knox Daily
Tyra Biosciences Inc (TYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.89%
0.13%
자본화:
|
볼륨(24시간):